Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 65 years or older
- People who are scheduled for planned or emergency hip surgery, such as surgery to repair a hip fracture or replace a hip joint
- People whose overall health status falls within a certain range as assessed by their anaesthetist or doctor (known as ASA physical status I–III — confirm with trial site if unsure what this means)
- People who are able to describe their pain level using a simple number rating scale
- People for whom written consent has been provided, either by themselves or by a legal representative
Who may not be able to join:
- People who are unwilling or unable to give informed consent to participate
- People with a known allergy, intolerance, or medical reason preventing the use of the study medication, ropivacaine (a local anaesthetic)
- People who already have nerve damage or a neurological condition affecting the leg or hip being treated
- People with blood clotting problems, or who are taking blood-thinning medications in a way that would make nerve block procedures unsafe
- People with a skin infection at or near the area where the injection would be given
- People with severely reduced liver or kidney function
- People who have been taking opioid pain medicines every day for more than 30 days before their surgery
- People whose thinking or memory difficulties would make it unreliable for them to report their pain levels
- People with a body mass index (BMI) over 40 kg/m²
- People who are already receiving a different type of regional nerve block for their hip surgery
- People who are pregnant or breastfeeding
- People who have taken part in another interventional clinical trial within the past 30 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Malgorzata Reysner, MD PhD, Poznan University of Medical Sciences
Phone: +48 61 873 83 03
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
otal Opioid Consumption
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.